Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06723041 · ClinicalTrials.gov registry record · NA

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

A NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT06723041 is a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 78 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06723041, a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

This clinicaI trial is being done to determine if acupressure is helpful to reduce anxiety related to chemotherapy, compared with "sham" (or placebo) acupressure in patients with cancer. Anxiety, experienced by many patients with cancer, can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicine ways to manage symptoms. Acupressure is the application of non-invasive finger pressure along energy points throughout the body in order to relieve pain and induce a feeling of well-being. Previous research has shown that acupressure can help both adults and children with their anxiety in certain situations, such as after surgery. Patients can be taught how to do the acupressure on themselves, making this an intervention that can be done anywhere. Acupressure is well tolerated with minimal reports of adverse reactions. Undergoing acupressure may be effective in reducing anxiety in cancer patients receiving chemotherapy.

Interventions

  • OTHER Survey Administration
  • PROCEDURE Acupressure Therapy
  • PROCEDURE Acupressure Therapy - placebo
  • PROCEDURE Acupressure Therapy - self-administered
  • OTHER Health Promotion and Education

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2024-12-11
Est. Completion 2026-12-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06723041

The ClinicalTrials.gov registry entry for NCT06723041 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (93% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Survey Administration is the first listed.

NCT06723041 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06723041 about?

NCT06723041 is a clinical study titled "Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy". This clinicaI trial is being done to determine if acupressure is helpful to reduce anxiety related to chemotherapy, compared with "sham" (or placebo) acupressure in patients with cancer. Anxiety, experienced by many patients with cancer, can be related to chemotherapy and may contribute to other sym...

What is the current status of trial NCT06723041?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2024-12-11. Estimated completion is 2026-12-31.

What conditions does trial NCT06723041 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm.

What interventions are being tested in trial NCT06723041?

The interventions under investigation include: Survey Administration (OTHER), Acupressure Therapy (PROCEDURE), Acupressure Therapy - placebo (PROCEDURE), Acupressure Therapy - self-administered (PROCEDURE), Health Promotion and Education (OTHER).

Who is sponsoring clinical trial NCT06723041?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06723041 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.